NOVOCURE LIMITED revenue breakdown overview

NOVOCURE LIMITED revenue for the last year amounted to 12.62 B MXN, the most of which — 12.62 B MXN — came from its highest performing source at the moment, Tumor Treating Fields, the year earlier bringing 8.65 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought NOVOCURE LIMITED 8.17 B MXN, and the year before that — 5.94 B MXN.